268 related articles for article (PubMed ID: 9441076)
1. Two-step tuberculin skin testing of injection drug users recruited from community-based settings.
Lifson AR; Grant SM; Lorvick J; Pinto FD; He H; Thompson S; Keudell EG; Stark MJ; Booth RE; Watters JK
Int J Tuberc Lung Dis; 1997 Apr; 1(2):128-34. PubMed ID: 9441076
[TBL] [Abstract][Full Text] [Related]
2. Tuberculin skin testing in intravenous drug users: differences between HIV-seropositive and HIV-seronegative subjects.
Portu JJ; Aldamiz-Etxebarria M; Agud JM; Arévalo JM; Almaraz MJ; Ayensa C
Addict Biol; 2002 Apr; 7(2):235-41. PubMed ID: 12006219
[TBL] [Abstract][Full Text] [Related]
3. Yield of tuberculin screening among injection drug users.
Brassard P; Bruneau J; Schwartzman K; Sénécal M; Menzies D
Int J Tuberc Lung Dis; 2004 Aug; 8(8):988-93. PubMed ID: 15305482
[TBL] [Abstract][Full Text] [Related]
4. Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection.
Caiaffa WT; Graham NM; Galai N; Rizzo RT; Nelson KE; Vlahov D
Arch Intern Med; 1995 Oct; 155(19):2111-7. PubMed ID: 7575072
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Mycobacterium tuberculosis infection among injection drug users in Toronto.
Rusen ID; Yuan L; Millson ME
CMAJ; 1999 Mar; 160(6):799-802. PubMed ID: 10189423
[TBL] [Abstract][Full Text] [Related]
6. Agreement between Mantoux skin testing and QuantiFERON-TB assay using dual mycobacterial antigens in current and former injection drug users.
Shah SS; McGowan JP; Klein RS; Converse PJ; Blum S; Gourevitch MN
Med Sci Monit; 2006 Apr; 12(4):MT11-6. PubMed ID: 16572060
[TBL] [Abstract][Full Text] [Related]
7. Utility of tuberculin and anergy skin testing in predicting tuberculosis infection in human immunodeficiency virus-infected persons in Thailand.
Yanai H; Uthaivoravit W; Mastro TD; Limpakarnjanarat K; Sawanpanyalert P; Morrow RH; Nieburg P
Int J Tuberc Lung Dis; 1997 Oct; 1(5):427-34. PubMed ID: 9441097
[TBL] [Abstract][Full Text] [Related]
8. [Tuberculin test in HIV infection].
Portu JJ; Pérez JR; Arévalo JM; Aldamiz-Etxebarria M; Agud JM; Ayensa C
Enferm Infecc Microbiol Clin; 1996 Feb; 14(2):90-5. PubMed ID: 8714155
[TBL] [Abstract][Full Text] [Related]
9. Routine two-step skin testing for tuberculosis in the staff of a geriatric hospital in Israel: booster and conversion rates.
Srour-Fihmi S; Weiler-Ravell D; Kitzes R; Chemtob D
J Hosp Infect; 2000 Oct; 46(2):141-6. PubMed ID: 11049708
[TBL] [Abstract][Full Text] [Related]
10. Increasing the use of bleach and condoms among injecting drug users in Denver: outcomes of a targeted, community-level HIV prevention program.
Rietmeijer CA; Kane MS; Simons PZ; Corby NH; Wolitski RJ; Higgins DL; Judson FN; Cohn DL
AIDS; 1996 Mar; 10(3):291-8. PubMed ID: 8882669
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection.
Selwyn PA; Hartel D; Lewis VA; Schoenbaum EE; Vermund SH; Klein RS; Walker AT; Friedland GH
N Engl J Med; 1989 Mar; 320(9):545-50. PubMed ID: 2915665
[TBL] [Abstract][Full Text] [Related]
12. School based screening for tuberculosis infection in Norway: comparison of positive tuberculin skin test with interferon-gamma release assay.
Winje BA; Oftung F; Korsvold GE; Mannsåker T; Ly IN; Harstad I; Dyrhol-Riise AM; Heldal E
BMC Infect Dis; 2008 Oct; 8():140. PubMed ID: 18928541
[TBL] [Abstract][Full Text] [Related]
13. Comparison between a whole blood interferon-gamma release assay and tuberculin skin testing for the detection of tuberculosis infection among patients at risk for tuberculosis exposure.
Kimura M; Converse PJ; Astemborski J; Rothel JS; Vlahov D; Comstock GW; Graham NM; Chaisson RE; Bishai WR
J Infect Dis; 1999 May; 179(5):1297-300. PubMed ID: 10191241
[TBL] [Abstract][Full Text] [Related]
14. Lack of direct correlation between CD4 T-lymphocyte counts and induration sizes of the tuberculin skin test in human immunodeficiency virus type 1 seropositive patients.
Diagbouga S; Fumoux F; Ledru E; Sanou PT; Barro D; Marchal G
Int J Tuberc Lung Dis; 1998 Apr; 2(4):317-23. PubMed ID: 9559403
[TBL] [Abstract][Full Text] [Related]
15. Tuberculosis screening in internationally adopted children: the need for initial and repeat testing.
Trehan I; Meinzen-Derr JK; Jamison L; Staat MA
Pediatrics; 2008 Jul; 122(1):e7-14. PubMed ID: 18595977
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of HIV and hepatitis B and self-reported injection risk behavior during detention among street-recruited injection drug users in Los Angeles County, 1994-1996.
López-Zetina J; Kerndt P; Ford W; Woerhle T; Weber M
Addiction; 2001 Apr; 96(4):589-95. PubMed ID: 11300962
[TBL] [Abstract][Full Text] [Related]
17. Two-step tuberculin skin testing in drug users.
Swaminathan S; Schoenbaum EE; Klein RS; Howard AA; Lo Y; Gourevitch MN
J Addict Dis; 2007; 26(2):71-9. PubMed ID: 17595000
[TBL] [Abstract][Full Text] [Related]
18. Mycobacterium tuberculosis infection among crack and injection drug users in San Juan, Puerto Rico.
Reyes JC; Robles RR; Colón HM; Marrero CA; Castillo X; Meléndez M
P R Health Sci J; 1996 Sep; 15(3):233-6. PubMed ID: 8994290
[TBL] [Abstract][Full Text] [Related]
19. An alternative to 'two-step' tuberculin skin testing for Southeast Asian refugees.
Wenzel M
Nurse Pract; 1991 Sep; 16(9):25-8. PubMed ID: 1945074
[TBL] [Abstract][Full Text] [Related]
20. Influence of the human immunodeficiency virus in the incidence of tuberculosis in a cohort of intravenous drug users: effectiveness of anti-tuberculosis chemoprophylaxis.
Jansà JM; Serrano J; Caylà JA; Vidal R; Ocaña I; Español T
Int J Tuberc Lung Dis; 1998 Feb; 2(2):140-6. PubMed ID: 9580481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
